Microenvironmental regulation of biomacromolecular therapies

[1]  A. Seifalian,et al.  Nanocomposite containing bioactive peptides promote endothelialisation by circulating progenitor cells: an in vitro evaluation. , 2006, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[2]  C. Linge,et al.  Distinct patterns of microvascular endothelial cell morphology are determined by extracellular matrix composition. , 2004, Endothelium : journal of endothelial cell research.

[3]  D. Cheresh,et al.  The role of alphav integrins during angiogenesis: insights into potential mechanisms of action and clinical development. , 1999, The Journal of clinical investigation.

[4]  A. Shah,et al.  Targeting αvβ3 and α5β1 for gene delivery to proliferating VSMCs: synergistic effect of TGF-β1 , 2003 .

[5]  G. Whitesides,et al.  New approaches to nanofabrication: molding, printing, and other techniques. , 2005, Chemical reviews.

[6]  D. Mooney,et al.  Polymeric system for dual growth factor delivery , 2001, Nature Biotechnology.

[7]  M. Morris,et al.  A peptide carrier for the delivery of biologically active proteins into mammalian cells , 2001, Nature Biotechnology.

[8]  R. Mrsny.  Strategies for targeting protein therapeutics to selected tissues and cells , 2004, Expert opinion on biological therapy.

[9]  D. Guyer,et al.  Pegaptanib, a targeted anti-VEGF aptamer for ocular vascular disease , 2006, Nature Reviews Drug Discovery.

[10]  M. Behlke.  Progress towards in Vivo Use of siRNAs , 2006, Molecular Therapy.

[11]  L G Griffith,et al.  Biophysical integration of effects of epidermal growth factor and fibronectin on fibroblast migration. , 1999, Biophysical journal.

[12]  Steven G Potkin,et al.  A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease , 2005, Nature Medicine.

[13]  Melinda Larsen,et al.  Fibronectin requirement in branching morphogenesis , 2003, Nature.

[14]  G. Whitesides,et al.  Microfluidic devices fabricated in Poly(dimethylsiloxane) for biological studies , 2003, Electrophoresis.

[15]  L. Griffith,et al.  Capturing complex 3D tissue physiology in vitro , 2006, Nature Reviews Molecular Cell Biology.

[16]  T. Giorgio,et al.  Convective flow increases lipoplex delivery rate to in vitro cellular monolayers , 2005, Gene Therapy.

[17]  P. Janmey,et al.  Tissue Cells Feel and Respond to the Stiffness of Their Substrate , 2005, Science.

[18]  L. Mir,et al.  Variability of naked DNA expression after direct local injection: the influence of the injection speed , 2006, Gene Therapy.

[19]  I. Kato,et al.  Adhesion to fibronectin maintains regenerative capacity during ex vivo culture and transduction of human hematopoietic stem and progenitor cells. , 1998, Blood.

[20]  C. Mailhos,et al.  Inhibition of platelet-derived growth factor B signaling enhances the efficacy of anti-vascular endothelial growth factor therapy in multiple models of ocular neovascularization. , 2006, The American journal of pathology.

[21]  David J Mooney,et al.  Coating of VEGF-releasing scaffolds with bioactive glass for angiogenesis and bone regeneration. , 2006, Biomaterials.

[22]  Soong Ho Um,et al.  Enzyme-catalysed assembly of DNA hydrogel , 2006, Nature materials.

[23]  D. Yamashiro,et al.  Vascular remodeling and clinical resistance to antiangiogenic cancer therapy. , 2004, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

[24]  A. Dritschilo,et al.  RAF antisense oligonucleotide as a tumor radiosensitizer , 2003, Oncogene.

[25]  Yutaka Ikeda,et al.  Ligand-Targeted Delivery of Therapeutic siRNA , 2006, Pharmaceutical Research.

[26]  G. Hortobagyi,et al.  Recent advances in the application of gene therapy to human disease. , 1995, The American journal of medicine.

[27]  P. Lambin,et al.  Specific targeting of cytosine deaminase to solid tumors by engineered Clostridium acetobutylicum , 2001, Cancer Gene Therapy.

[28]  R. Sainson,et al.  Angiogenic sprouting and capillary lumen formation modeled by human umbilical vein endothelial cells (HUVEC) in fibrin gels: the role of fibroblasts and Angiopoietin-1. , 2003, Microvascular research.

[29]  D E Ingber,et al.  Convergence of integrin and growth factor receptor signaling pathways within the focal adhesion complex. , 1995, Molecular biology of the cell.

[30]  H. Augustin,et al.  Tensional forces in fibrillar extracellular matrices control directional capillary sprouting. , 1999, Journal of cell science.

[31]  G. Tobin,et al.  Impediments to wound healing. , 1998, American journal of surgery.

[32]  J. Tidball.  Biomechanics and Mechanotransduction in Cells and Tissues Mechanical signal transduction in skeletal muscle growth and adaptation , 2005 .

[33]  Benjamin G Keselowsky,et al.  Surface chemistry modulates fibronectin conformation and directs integrin binding and specificity to control cell adhesion. , 2003, Journal of biomedical materials research. Part A.

[34]  H. Vandenburgh,et al.  Recombinant Vascular Endothelial Growth Factor Secreted From Tissue-Engineered Bioartificial Muscles Promotes Localized Angiogenesis , 2001, Circulation.

[35]  F. Ledley.  Nonviral gene therapy: the promise of genes as pharmaceutical products. , 1995, Human gene therapy.

[36]  W. Mark Saltzman,et al.  Synthetic DNA delivery systems , 2000, Nature Biotechnology.

[37]  Jeffrey Bonadio,et al.  Localized, direct plasmid gene delivery in vivo: prolonged therapy results in reproducible tissue regeneration , 1999, Nature Medicine.

[38]  H. Vandenburgh,et al.  Paracrine release of insulin-like growth factor 1 from a bioengineered tissue stimulates skeletal muscle growth in vitro. , 2006, Tissue engineering.

[39]  S. Achatz,et al.  Vascular gene delivery of anticoagulants by transplantation of retrovirally-transduced endothelial progenitor cells. , 2003, Cardiovascular research.

[40]  Cynthia A. Reinhart-King,et al.  Tensional homeostasis and the malignant phenotype. , 2005, Cancer cell.

[41]  F R Haselton,et al.  Mitosis enhances transgene expression of plasmid delivered by cationic liposomes. , 1999, Biochimica et biophysica acta.

[42]  G. Korbutt,et al.  Glucose-dependent insulin release from genetically engineered K cells. , 2000, Science.

[43]  K. Shakesheff,et al.  Spatial confinement of neurite regrowth from dorsal root ganglia within nonporous microconduits. , 2003, Tissue engineering.

[44]  Y. Tabata,et al.  Tissue engineering by modulated gene delivery. , 2006, Advanced drug delivery reviews.

[45]  R. Day,et al.  Myofibroblast Differentiation by Transforming Growth Factor-β1 Is Dependent on Cell Adhesion and Integrin Signaling via Focal Adhesion Kinase* , 2003, Journal of Biological Chemistry.

[46]  Y. Ito,et al.  Differential control of cellular gene expression by diffusible and non-diffusible EGF. , 2001, Journal of biochemistry.

[47]  David J Mooney,et al.  Modifying the proliferative state of target cells to control DNA expression and identifying cell types transfected in vivo. , 2007, Molecular therapy : the journal of the American Society of Gene Therapy.

[48]  D. Mooney,et al.  Regulating activation of transplanted cells controls tissue regeneration. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[49]  Susan X. Hsiong,et al.  Nanoscale cell adhesion ligand presentation regulates nonviral gene delivery and expression. , 2007, Nano letters.

[50]  M. Simons,et al.  Growth factor-induced therapeutic angiogenesis in the heart: protein therapy. , 2005, Cardiovascular research.

[51]  D. Cheresh,et al.  Requirement of vascular integrin alpha v beta 3 for angiogenesis. , 1994, Science.

[52]  R. Langer,et al.  Drug delivery and targeting. , 1998, Nature.

[53]  Scott D. Putney,et al.  Improving protein therapeutics with sustained-release formulations , 1998, Nature Biotechnology.

[54]  W. Saltzman,et al.  Surface-mediated gene transfer from nanocomposites of controlled texture , 2004, Nature materials.

[55]  B. Robinson,et al.  Advances in malignant mesothelioma. , 2005, The New England journal of medicine.

[56]  J. Isner,et al.  Arterial gene transfer of naked DNA for therapeutic angiogenesis: early clinical results. , 1998, Advanced drug delivery reviews.

[57]  David J. Mooney,et al.  Non-viral gene delivery regulated by stiffness of cell adhesion substrates , 2005, Nature materials.

[58]  J. Priller,et al.  Marrow-derived cells as vehicles for delivery of gene therapy to pulmonary epithelium. , 2002, American journal of respiratory cell and molecular biology.

[59]  J. Urban,et al.  Nutrition of the Intervertebral Disc , 2004, Spine.

[60]  K. Ohya,et al.  Bone regeneration by modified gene-activated matrix: effectiveness in segmental tibial defects in rats. , 2006, Tissue engineering.

[61]  A. Sutton,et al.  The response of endothelial cells to TGF beta-1 is dependent upon cell shape, proliferative state and the nature of the substratum. , 1991, Journal of cell science.

[62]  Christopher S. Chen,et al.  Engineering cellular microenvironments to improve cell-based drug testing. , 2002, Drug discovery today.

[63]  D. Scadden,et al.  Osteoblastic cells regulate the haematopoietic stem cell niche , 2003, Nature.

[64]  I. Laurendeau,et al.  Low molecular weight fucoidan and heparin enhance the basic fibroblast growth factor-induced tube formation of endothelial cells through heparan sulfate-dependent alpha6 overexpression. , 2003, Molecular pharmacology.

[65]  A. Khademhosseini,et al.  Microscale technologies for tissue engineering and biology. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[66]  Benjamin Geiger,et al.  TRANSMEMBRANE EXTRACELLULAR MATRIX – CYTOSKELETON CROSSTALK , 2001 .

[67]  E. Kovacs,et al.  Fibrogenic cytokines and connective tissue production , 1994, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[68]  S. Haslam,et al.  The Role of Mammary Stroma in Modulating the Proliferative Response to Ovarian Hormones in the Normal Mammary Gland , 1998, Journal of Mammary Gland Biology and Neoplasia.

[69]  David J. Mooney,et al.  DNA delivery from polymer matrices for tissue engineering , 1999, Nature Biotechnology.

[70]  M Angela Taipa,et al.  Antibodies and Genetically Engineered Related Molecules: Production and Purification , 2004, Biotechnology progress.

[71]  D H Kohn,et al.  Sustained release of vascular endothelial growth factor from mineralized poly(lactide-co-glycolide) scaffolds for tissue engineering. , 2000, Biomaterials.

[72]  B. Nayak,et al.  Augmenting the immunogenicity of DNA vaccines: role of plasmid-encoded Flt-3 ligand, as a molecular adjuvant in genetic vaccination. , 2006, Virology.

[73]  David A. Williams,et al.  Simultaneous Infection with Retroviruses Pseudotyped with Different Envelope Proteins Bypasses Viral Receptor Interference Associated with Colocalization of gp70 and Target Cells on Fibronectin CH-296 , 1999, Journal of Virology.

[74]  Salman Rahman,et al.  Novel Vascular Endothelial Growth Factor Binding Domains of Fibronectin Enhance Vascular Endothelial Growth Factor Biological Activity , 2002, Circulation research.

[75]  R. Callaghan,et al.  Optimising non‐viral gene delivery in a tumour spheroid model , 2006, The journal of gene medicine.

[76]  Masakazu Toi,et al.  Angiogenic inhibitors: a new therapeutic strategy in oncology , 2005, Nature Clinical Practice Oncology.

[77]  Lee M Ellis,et al.  Improving delivery of antineoplastic agents with anti‐vascular endothelial growth factor therapy , 2005, Cancer.

[78]  David J Mooney,et al.  Protein-based signaling systems in tissue engineering. , 2003, Current opinion in biotechnology.

[79]  T. Mukhopadhyay,et al.  Antisense therapy for cancer. , 1995, The cancer journal from Scientific American.

[80]  C. Larabell,et al.  Reciprocal interactions between beta1-integrin and epidermal growth factor receptor in three-dimensional basement membrane breast cultures: a different perspective in epithelial biology. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[81]  P. Steeg.  Tumor metastasis: mechanistic insights and clinical challenges , 2006, Nature Medicine.

[82]  R. Cartier,et al.  Utilization of synthetic peptides containing nuclear localization signals for nonviral gene transfer systems , 2002, Gene Therapy.

[83]  Qing Ge,et al.  Inhibition of influenza virus production in virus-infected mice by RNA interference. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[84]  P. Bourin,et al.  Short-term injection of antiapoptotic cytokine combinations soon after lethal gamma -irradiation promotes survival. , 2003, Blood.

[85]  E G Tuddenham,et al.  The hemophilias--from royal genes to gene therapy. , 2001, The New England journal of medicine.

[86]  David A. Williams,et al.  Colocalization of retrovirus and target cells on specific fibronectin fragments increases genetic transduction of mammalian cells , 1996, Nature Medicine.

[87]  A. Pavlou,et al.  Recombinant protein therapeutics—success rates, market trends and values to 2010 , 2004, Nature Biotechnology.

[88]  M. Tuszynski,et al.  Nerve growth factor: from animal models of cholinergic neuronal degeneration to gene therapy in Alzheimer's disease. , 2004, Progress in brain research.

[89]  Jennifer Linderman,et al.  Nanoscale Adhesion Ligand Organization Regulates Osteoblast Proliferation and Differentiation. , 2004, Nano letters.

[90]  Franz E Weber,et al.  Bone repair with a form of BMP-2 engineered for incorporation into fibrin cell ingrowth matrices. , 2005, Biotechnology and bioengineering.

[91]  D. Mooney,et al.  Combined Angiogenic and Osteogenic Factor Delivery Enhances Bone Marrow Stromal Cell‐Driven Bone Regeneration , 2004, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[92]  R. Juliano,et al.  Integrin Signaling , 2005, Cancer and Metastasis Reviews.

[93]  Anthony Atala,et al.  Continuous release of endostatin from microencapsulated engineered cells for tumor therapy , 2001, Nature Biotechnology.

[94]  Eben Alsberg,et al.  Dual growth factor delivery and controlled scaffold degradation enhance in vivo bone formation by transplanted bone marrow stromal cells. , 2004, Bone.

[95]  Daniel W. Pack,et al.  Design and development of polymers for gene delivery , 2005, Nature Reviews Drug Discovery.

[96]  I. Laurendeau,et al.  Low Molecular Weight Fucoidan and Heparin Enhance the Basic Fibroblast Growth Factor-Induced Tube Formation of Endothelial Cells through Heparan Sulfate-Dependent (cid:1) 6 Overexpression , 2003 .

[97]  D. Mahvi,et al.  Granulocyte-macrophage colony-stimulating factor (GM-CSF) secreted by cDNA-transfected tumor cells induces a more potent antitumor response than exogenous GM-CSF , 1999, Cancer Gene Therapy.

[98]  Yang-Jo Seol,et al.  Enhanced bone formation by controlled growth factor delivery from chitosan-based biomaterials. , 2002, Journal of controlled release : official journal of the Controlled Release Society.

[99]  R. Langer,et al.  Designing materials for biology and medicine , 2004, Nature.

[100]  Sung Wan Kim,et al.  Current status of polymeric gene delivery systems. , 2006, Advanced drug delivery reviews.

[101]  R. Jain.  Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy , 2005, Science.

[102]  J. Hubbell,et al.  Synthetic biomaterials as instructive extracellular microenvironments for morphogenesis in tissue engineering , 2005, Nature Biotechnology.

[103]  Eben Alsberg,et al.  FRET measurements of cell-traction forces and nano-scale clustering of adhesion ligands varied by substrate stiffness. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[104]  I. Tannock,et al.  Drug penetration in solid tumours , 2006, Nature Reviews Cancer.

[105]  Richard T. Lee,et al.  Cell mechanics and mechanotransduction: pathways, probes, and physiology. , 2004, American journal of physiology. Cell physiology.

[106]  Sophie Lelièvre,et al.  beta4 integrin-dependent formation of polarized three-dimensional architecture confers resistance to apoptosis in normal and malignant mammary epithelium. , 2002, Cancer cell.

[107]  David J Mooney,et al.  Sustained delivery of plasmid DNA from polymeric scaffolds for tissue engineering. , 2006, Advanced drug delivery reviews.

[108]  R. Taichman.  Blood and bone: two tissues whose fates are intertwined to create the hematopoietic stem-cell niche. , 2005, Blood.

[109]  David J. Mooney,et al.  Polymeric Growth Factor Delivery Strategies for Tissue Engineering , 2003, Pharmaceutical Research.

[110]  Joungho Han,et al.  Synergistic Effect of Keratinocyte Transplantation and Epidermal Growth Factor Delivery on Epidermal Regeneration , 2005, Cell transplantation.

[111]  Martin Ehrbar,et al.  Cell‐demanded release of VEGF from synthetic, biointeractive cell‐ingrowth matrices for vascularized tissue growth , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[112]  W. Sadee,et al.  Protein therapeutics: new applications for pharmacogenetics , 2006, Nature Reviews Drug Discovery.

[113]  Urban Deutsch,et al.  Angiopoietin-1 induces sprouting angiogenesis in vitro , 1998, Current Biology.

[114]  A. Maghazachi,et al.  Chemokines activate natural killer cells through heterotrimeric G‐proteins: implications for the treatment of AIDS and cancer , 1998, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[115]  E. Poeschla,et al.  Progress towards gene therapy for HIV infection. , 1994, Gene therapy.

[116]  J. Isner.  Myocardial gene therapy , 2002, Nature.

[117]  N. Mechti,et al.  Extracellular matrix in bone marrow can mediate drug resistance in myeloma , 2005, Leukemia & lymphoma.

[118]  Hisatoshi Kobayashi,et al.  Combination of 3D tissue engineered scaffold and non-viral gene carrier enhance in vitro DNA expression of mesenchymal stem cells. , 2006, Biomaterials.

[119]  Donald E. Ingber,et al.  How does extracellular matrix control capillary morphogenesis? , 1989, Cell.

[120]  T D Brown,et al.  Techniques for mechanical stimulation of cells in vitro: a review. , 2000, Journal of biomechanics.

[121]  Ralph Müller,et al.  Repair of bone defects using synthetic mimetics of collagenous extracellular matrices , 2003, Nature Biotechnology.

[122]  D. Cumberland,et al.  Ultrasound enhances reporter gene expression after transfection of vascular cells in vitro. , 1999, Circulation.

[123]  M. Poupon,et al.  Distinctive alterations of invasiveness, drug resistance and cell–cell organization in 3D-cultures of MCF-7, a human breast cancer cell line, and its multidrug resistant variant , 2004, Clinical & Experimental Metastasis.

[124]  C. S. Chen,et al.  Geometric control of cell life and death. , 1997, Science.

[125]  D. Scherman,et al.  Critical assessment of the nuclear import of plasmid during cationic lipid‐mediated gene transfer , 2001, The journal of gene medicine.

[126]  Donald E Ingber,et al.  Mechanobiology and diseases of mechanotransduction , 2003, Annals of medicine.

[127]  Kenneth M. Yamada,et al.  Transmembrane crosstalk between the extracellular matrix and the cytoskeleton , 2001, Nature Reviews Molecular Cell Biology.

[128]  A. Reddi,et al.  The application of bone morphogenetic proteins to dental tissue engineering , 2003, Nature Biotechnology.

[129]  L G Griffith,et al.  Cell adhesion and motility depend on nanoscale RGD clustering. , 2000, Journal of cell science.

[130]  C. Addison,et al.  The response of VEGF-stimulated endothelial cells to angiostatic molecules is substrate-dependent , 2005, BMC Cell Biology.

[131]  Martin Ehrbar,et al.  Endothelial cell proliferation and progenitor maturation by fibrin-bound VEGF variants with differential susceptibilities to local cellular activity. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[132]  M. S. Park,et al.  Enhancement of the osteogenic efficacy of osteoblast transplantation by the sustained delivery of basic fibroblast growth factor. , 2006, Journal of biomedical materials research. Part B, Applied biomaterials.

[133]  J. Talmadge,et al.  The pharmaceutics and delivery of therapeutic polypeptides and proteins , 1993 .

[134]  S. Schwarze,et al.  In vivo protein transduction: delivery of a biologically active protein into the mouse. , 1999, Science.

[135]  T. Gerngross,et al.  Advances in the production of human therapeutic proteins in yeasts and filamentous fungi , 2004, Nature Biotechnology.

[136]  Wim E. Hennink,et al.  Artificial viruses: a nanotechnological approach to gene delivery , 2006, Nature Reviews Drug Discovery.

[137]  L. Mir,et al.  Mechanisms of in vivo DNA electrotransfer: respective contributions of cell electropermeabilization and DNA electrophoresis. , 2002, Molecular therapy : the journal of the American Society of Gene Therapy.

[138]  S. Haslam,et al.  Proliferation of mouse mammary epithelial cells in vitro: interactions among epidermal growth factor, insulin-like growth factor I, ovarian hormones, and extracellular matrix proteins. , 2000, Endocrinology.

[139]  R. Storb,et al.  The use of granulocyte colony-stimulating factor during retroviral transduction on fibronectin fragment CH-296 enhances gene transfer into hematopoietic repopulating cells in dogs. , 1999, Blood.

[140]  U. Bickel,et al.  Delivery of peptides and proteins through the blood-brain barrier. , 1993, Advanced drug delivery reviews.

[141]  Richard T. Lee,et al.  Local myocardial insulin-like growth factor 1 (IGF-1) delivery with biotinylated peptide nanofibers improves cell therapy for myocardial infarction. , 2006, Proceedings of the National Academy of Sciences of the United States of America.